Cobepa is a private equity firm with a diverse portfolio across sectors such as healthcare, business services, and tech-enabled services. Established in 1957, the company partners with management teams to enhance growth and sustainability of its investments, managing over 4.4 billion euros in assets. Cobepa operates globally with offices in Brussels, Munich, and New York, focusing on long-term value creation without sector-specific limitations.
- Biotechnology
- Pharmaceuticals
- Healthcare
- Life Sciences
- Contract Research Organization (Cro)
- Drug Discovery
- Preclinical Services
- Cancer Therapeutics
- Biopharmaceutical Services
Leadership
Name | Title | ||
---|---|---|---|
Andrew Hollod | Managing Director |
in/andrew-hollod-58a06015
|
|
Group Managing Director |
|
|
Recent Transactions involving Cobepa
Deal | Target | Platform | Buyer | Industry |
---|---|---|---|---|
SOCOTEC US Doubles in Size with Transformative Acquisition of Ninyo & Moore |
Ninyo & Moore |
SOCOTEC Group |
Cobepa |
Geotechnical and Environmental Engineering |
|
|
|
|
|
|
|
|
||
|
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →